Evidence map›Paper›PMID 38095311›Full record

ArticleJournal of biomedical materials research. Part A2024

Compliant substrates mitigate the senescence associated phenotype of stress induced mesenchymal stromal cells.

Robert C H Gresham, Andrea C Filler, Shierly W Fok, Molly Czachor, Natalie Schmier, Claire Pearson, Chelsea Bahney, J Kent Leach

Open access · hybridAbstract read
In one paragraph

Article in Journal of biomedical materials research. Part A, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Robert C H GreshamDepartment of Orthopaedic Surgery, School of Medicine, UC Davis Health, Sacramento, California, USA.
Andrea C FillerDepartment of Orthopaedic Surgery, School of Medicine, UC Davis Health, Sacramento, California, USA.
Shierly W FokDepartment of Orthopaedic Surgery, School of Medicine, UC Davis Health, Sacramento, California, USA.
Molly CzachorCenter for Regenerative and Personalized Medicine, Steadman Phillippon Research Institute, Vail, Colorado, USA.
Natalie SchmierDepartment of Orthopaedic Surgery, School of Medicine, UC Davis Health, Sacramento, California, USA.
Claire PearsonDepartment of Orthopaedic Surgery, School of Medicine, UC Davis Health, Sacramento, California, USA.
Chelsea BahneyCenter for Regenerative and Personalized Medicine, Steadman Phillippon Research Institute, Vail, Colorado, USA.
J Kent LeachDepartment of Orthopaedic Surgery, School of Medicine, UC Davis Health, Sacramento, California, USA.ORCID 0000-0002-1673-3335
University of California, Davis · USSteadman Philippon Research Institute · US

Funding

Identifying the superior ossification pathway for tissue engineered approaches to long bone repairR01AR079211 · NIAMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI LEACH, J. KENT · 2021 to 2025
$1.9M
MUSCLE: MUsculoSkeletal Clinical Learning Experience Transdisciplinary Musculoskeletal Research Training ProgramT32AR079099 · NIAMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI J. Kent Leach, Robert L. Randall · 2022 to 2026
$844k
NIAMS NIH HHS R01 AR079211NIAMS NIH HHS R01AR079211NIAMS NIH HHS T32 AR079099NIAMS NIH HHS T32AR079099NIH HHS
6 · The paper itself

Abstract

Mesenchymal stromal cells (MSCs) are a promising cell population for musculoskeletal cell-based therapies due to their multipotent differentiation capacity and complex secretome. Cells from younger donors are mechanosensitive, evidenced by changes in cell morphology, adhesivity, and differentiation as a function of substrate stiffness in both two- and three-dimensional culture. However, MSCs from older individuals exhibit reduced differentiation potential and increased senescence, limiting their potential for autologous use. While substrate stiffness is known to modulate cell phenotype, the influence of the mechanical environment on senescent MSCs is poorly described. To address this question, we cultured irradiation induced premature senescent MSCs on polyacrylamide hydrogels and assessed expression of senescent markers, cell morphology, and secretion of inflammatory cytokines. Compared to cells on tissue culture plastic, senescent MSCs exhibited decreased markers of the senescence associated secretory phenotype (SASP) when cultured on 50 kPa gels, yet common markers of senescence (e.g., p21, CDKN2A, CDKN1A) were unaffected. These effects were muted in a physiologically relevant heterotypic mix of healthy and senescent MSCs. Conditioned media from senescent MSCs on compliant substrates increased osteoblast mineralization compared to conditioned media from cells on TCP. Mixed populations of senescent and healthy cells induced similar levels of osteoblast mineralization compared to healthy MSCs, further indicating an attenuation of the senescent phenotype in heterotypic populations. These data indicate that senescent MSCs exhibit a decrease in senescent phenotype when cultured on compliant substrates, which may be leveraged to improve autologous cell therapies for older donors.

Indexed as

Cellular SenescenceMesenchymal Stem CellsCell ProliferationCells, CulturedCulture Media, ConditionedHumansPhenotypeCulture Media, Conditionedmechanobiologymesenchymal stromal cellspolyacrylamideSASPsenescence

Identifiers

PMID38095311
PMCPMC10948313
OpenAlexW4389734406

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.